Propionic Acidemia Market Report 2026
Download Free Sample Buy Now
Propionic Acidemia Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Propionic Acidemia Market Report 2026

Global Outlook – By Drug Class (L-Carnitine, Antibiotics), By Route of Administration (Oral, Intravenous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Propionic Acidemia Market Overview

• Propionic Acidemia market size has reached to $2.07 billion in 2025

• Expected to grow to $2.53 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%

• Growth Driver: The Increase in Prevalence of Genetic Disorders Fueling the Growth of the Market Due to Rising Demand for Targeted Treatments and Early Detection

• Market Trend: Innovative mRNA-Based Therapies Advancing Treatment For Rare Genetic Disorders

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Propionic Acidemia Market?

Propionic Acidemia (PA) is a rare, inherited metabolic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, which is essential for breaking down certain amino acids and fatty acids. This deficiency leads to the accumulation of toxic compounds in the blood, causing severe symptoms such as metabolic crises, neurological damage, and, if left untreated, can be life-threatening, especially in infancy.

The main drug classes of propionic acidemia are l-carnitine, antibiotics. L-Carnitine refers to a naturally occurring compound that plays a key role in the transport of long-chain fatty acids into mitochondria, where they are oxidized to produce energy. The various route of administration includes oral, intravenous, intramuscular. These are distributed through various distribution channels such as hospital pharmacies, retail pharmacies, online pharmacies.

Propionic Acidemia Market Report bar graph

What Is The Propionic Acidemia Market Size and Share 2026?

The propionic acidemia market size has grown steadily in recent years. It will grow from $2.07 billion in 2025 to $2.15 billion in 2026 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to improvements in newborn screening programs, increased awareness of inherited metabolic disorders, availability of supportive drug therapies, expansion of specialized metabolic clinics, growth in rare disease research funding.

What Is The Propionic Acidemia Market Growth Forecast?

The propionic acidemia market size is expected to see steady growth in the next few years. It will grow to $2.53 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing development of gene and enzyme therapies, rising investments in orphan drug development, expansion of precision medicine approaches, growing adoption of telemedicine for chronic care, increasing collaboration between research institutions. Major trends in the forecast period include increasing focus on early diagnosis and screening, rising adoption of personalized treatment protocols, growing research in rare metabolic disorders, expansion of specialized drug therapies, enhanced patient monitoring and management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Propionic Acidemia Market Segmentation

1) By Drug Class: L-Carnitine, Antibiotics

2) By Route of Administration: Oral, Intravenous, Intramuscular

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By L-Carnitine Drug Class: Oral L-Carnitine, Injectable L-Carnitine

2) By Antibiotic Drug Class: Oral Antibiotics, Injectable Antibiotics

What Is The Driver Of The Propionic Acidemia Market?

The increasing prevalence of genetic disorders is expected to propel the growth of the propionic acidemia market going forward. Genetic disorders refer to the conditions caused by mutations or abnormalities in an individual's DNA, which can be inherited or occur spontaneously, affecting health and development. The increasing prevalence of genetic disorders is due to consanguineous marriages, as they increase the risk of inheriting recessive genetic mutations by allowing the same defective genes to be passed down from both parents, which significantly raises the likelihood of genetic conditions. Propionic acidemia enhances genetic disorder management by offering targeted treatments that address metabolic imbalances, improving patient outcomes. For instance, in February 2024, according to the Osservatorio Malattie Rare (OMAR), an Italy-based leading free, independent journalistic agency, in 2023, Italian medical centers identified 18 new disease causing genes and followed over 18, 000 patients with rare disease through regional networks. Therefore, the increasing prevalence of genetic disorders is driving the growth of the acidemia market.

Key Players In The Global Propionic Acidemia Market

Major companies operating in the propionic acidemia market report are Recordati Rare Diseases Inc, Horizon Therapeutics plc, Travere Therapeutics (Retrophin Inc), Mitsubishi Tanabe Pharma Corporation, Ultragenyx Pharmaceutical Inc, Moderna Inc, Krystal Biotech Inc, Astellas Pharma Inc, Synlogic Inc, Encoded Therapeutics Inc, BridgeBio Pharma Inc, VectivBio AG, Agios Pharmaceuticals Inc, CoA Therapeutics Inc, Imbria Pharmaceuticals Inc, Comet Therapeutics Inc, Swedish Orphan Biovitrum AB (Sobi), Regenacy Pharmaceuticals, Audentes Therapeutics, Vertex Pharmaceuticals.

Global Propionic Acidemia Market Trends and Insights

Major companies operating in the propionic acidemia market are focusing on developing innovative mRNA-based treatments to address the underlying genetic causes of the disease. mRNA therapies are a type of treatment that use messenger RNA to instruct cells to produce proteins that can prevent or treat diseases by targeting the underlying causes at a genetic level. For instance, in May 2023, Moderna, a US-based pharmaceutical and biotechnology company, presented interim data from the Phase 1/2 trial of mRNA-3927, an investigational mRNA therapy for propionic acidemia. The therapy uses mRNA to deliver functional copies of the PCCA and PCCB genes, restoring enzyme activity in the liver and potentially reducing metabolic decompensations, with this innovative treatment approach aiming to improve patient outcomes by addressing the genetic root cause of the disease, offering new hope for individuals affected by this rare metabolic disorder.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Propionic Acidemia Market?

In May 2023, Ironwood Pharmaceuticals Inc., a US-based biotechnology company, acquired VectivBio for approximately $1 billion USD. With this acquisition, Ironwood aims to strengthen its rare disease pipeline by leveraging VectivBio’s novel therapies, including investigational treatments for propionic acidemia. VectivBio is a Switzerland-based biotechnology company specialized in developing treatments for rare gastrointestinal and metabolic disorders.

Regional Outlook

North America was the largest region in the propionic acidemia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Propionic Acidemia Market?

The propionic acidemia market includes revenues earned by entities through enzyme replacement therapy (ERT), nutritional therapy services, personalized care management services, patient support programs, and pharmacogenomic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Propionic Acidemia Market Report 2026?

The propionic acidemia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the propionic acidemia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Propionic Acidemia Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.15 billion
Revenue Forecast In 2035 $2.53 billion
Growth Rate CAGR of 4.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Recordati Rare Diseases Inc, Horizon Therapeutics plc, Travere Therapeutics (Retrophin Inc), Mitsubishi Tanabe Pharma Corporation, Ultragenyx Pharmaceutical Inc, Moderna Inc, Krystal Biotech Inc, Astellas Pharma Inc, Synlogic Inc, Encoded Therapeutics Inc, BridgeBio Pharma Inc, VectivBio AG, Agios Pharmaceuticals Inc, CoA Therapeutics Inc, Imbria Pharmaceuticals Inc, Comet Therapeutics Inc, Swedish Orphan Biovitrum AB (Sobi), Regenacy Pharmaceuticals, Audentes Therapeutics, Vertex Pharmaceuticals.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Propionic Acidemia Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Propionic Acidemia Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Propionic Acidemia Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Propionic Acidemia Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Digitalization, Cloud, Big Data And Cybersecurity

4.1.3 Artificial Intelligence And Autonomous Intelligence

4.1.4 Fintech, Blockchain, Regtech And Digital Finance

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increasing Focus On Early Diagnosis And Screening

4.2.2 Rising Adoption Of Personalized Treatment Protocols

4.2.3 Growing Research In Rare Metabolic Disorders

4.2.4 Expansion Of Specialized Drug Therapies

4.2.5 Enhanced Patient Monitoring And Management

5. Propionic Acidemia Market Analysis Of End Use Industries

5.1 Hospitals And Specialty Clinics

5.2 Pediatric Care Centers

5.3 Metabolic Disorder Treatment Centers

5.4 Diagnostic Laboratories

5.5 Research Institutions

6. Propionic Acidemia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Propionic Acidemia Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Propionic Acidemia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Propionic Acidemia Market Size, Comparisons And Growth Rate Analysis

7.3. Global Propionic Acidemia Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Propionic Acidemia Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Propionic Acidemia Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Propionic Acidemia Market Segmentation

9.1. Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

L-Carnitine, Antibiotics

9.2. Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Intramuscular

9.3. Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.4. Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral L-Carnitine, Injectable L-Carnitine

9.5. Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Antibiotics, Injectable Antibiotics

10. Propionic Acidemia Market Regional And Country Analysis

10.1. Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Propionic Acidemia Market

11.1. Asia-Pacific Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Propionic Acidemia Market

12.1. China Propionic Acidemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Propionic Acidemia Market

13.1. India Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Propionic Acidemia Market

14.1. Japan Propionic Acidemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Propionic Acidemia Market

15.1. Australia Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Propionic Acidemia Market

16.1. Indonesia Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Propionic Acidemia Market

17.1. South Korea Propionic Acidemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Propionic Acidemia Market

18.1. Taiwan Propionic Acidemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Propionic Acidemia Market

19.1. South East Asia Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Propionic Acidemia Market

20.1. Western Europe Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Propionic Acidemia Market

21.1. UK Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Propionic Acidemia Market

22.1. Germany Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Propionic Acidemia Market

23.1. France Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Propionic Acidemia Market

24.1. Italy Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Propionic Acidemia Market

25.1. Spain Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Propionic Acidemia Market

26.1. Eastern Europe Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Propionic Acidemia Market

27.1. Russia Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Propionic Acidemia Market

28.1. North America Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Propionic Acidemia Market

29.1. USA Propionic Acidemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Propionic Acidemia Market

30.1. Canada Propionic Acidemia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Propionic Acidemia Market

31.1. South America Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Propionic Acidemia Market

32.1. Brazil Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Propionic Acidemia Market

33.1. Middle East Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Propionic Acidemia Market

34.1. Africa Propionic Acidemia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Propionic Acidemia Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Propionic Acidemia Market Regulatory and Investment Landscape

36. Propionic Acidemia Market Competitive Landscape And Company Profiles

36.1. Propionic Acidemia Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Propionic Acidemia Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Propionic Acidemia Market Company Profiles

36.3.1. Recordati Rare Diseases Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Travere Therapeutics (Retrophin Inc) Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Mitsubishi Tanabe Pharma Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Ultragenyx Pharmaceutical Inc Overview, Products and Services, Strategy and Financial Analysis

37. Propionic Acidemia Market Other Major And Innovative Companies

Moderna Inc, Krystal Biotech Inc, Astellas Pharma Inc, Synlogic Inc, Encoded Therapeutics Inc, BridgeBio Pharma Inc, VectivBio AG, Agios Pharmaceuticals Inc, CoA Therapeutics Inc, Imbria Pharmaceuticals Inc, Comet Therapeutics Inc, Swedish Orphan Biovitrum AB (Sobi), Regenacy Pharmaceuticals, Audentes Therapeutics, Vertex Pharmaceuticals

38. Global Propionic Acidemia Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Propionic Acidemia Market

40. Propionic Acidemia Market High Potential Countries, Segments and Strategies

40.1 Propionic Acidemia Market In 2030 - Countries Offering Most New Opportunities

40.2 Propionic Acidemia Market In 2030 - Segments Offering Most New Opportunities

40.3 Propionic Acidemia Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Propionic Acidemia Market, Overview Of Key Products - Product Examples
  • Table 2: Global Propionic Acidemia Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Propionic Acidemia Market, Supply Chain Analysis
  • Table 4: Global Propionic Acidemia Market, Major Raw Material Providers
  • Table 5: Global Propionic Acidemia Market, Major Resource Providers
  • Table 6: Global Propionic Acidemia Market, Major Manufacturers (Suppliers)
  • Table 7: Global Propionic Acidemia Market, Major Distributors And Channel Partners
  • Table 8: Global Propionic Acidemia Market, Key Technologies & Future Trends
  • Table 9: Global Propionic Acidemia Market, Major Trends
  • Table 10: Global Propionic Acidemia Market, Major End Users
  • Table 11: Global Propionic Acidemia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Propionic Acidemia Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Propionic Acidemia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Propionic Acidemia Market - TAM, US$ Billion, 2025
  • Table 15: Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Propionic Acidemia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Propionic Acidemia Market - Company Scoring Matrix
  • Table 96: Recordati Rare Diseases Inc Financial Performance
  • Table 97: Horizon Therapeutics plc Financial Performance
  • Table 98: Travere Therapeutics (Retrophin Inc) Financial Performance
  • Table 99: Mitsubishi Tanabe Pharma Corporation Financial Performance
  • Table 100: Ultragenyx Pharmaceutical Inc Financial Performance
  • Table 101: Global Propionic Acidemia Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Propionic Acidemia Market, Competitive Dashboard
  • Table 103: Global Propionic Acidemia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Propionic Acidemia Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 105: Global, Propionic Acidemia Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Table 106: Global, Propionic Acidemia Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Propionic Acidemia Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Propionic Acidemia Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Propionic Acidemia Market, Supply Chain Analysis
  • Figure 4: Global Propionic Acidemia Market, Major Raw Material Providers
  • Figure 5: Global Propionic Acidemia Market, Major Resource Providers
  • Figure 6: Global Propionic Acidemia Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Propionic Acidemia Market, Major Distributors And Channel Partners
  • Figure 8: Global Propionic Acidemia Market, Key Technologies & Future Trends
  • Figure 9: Global Propionic Acidemia Market, Major Trends
  • Figure 10: Global Propionic Acidemia Market, Major End Users
  • Figure 11: Global Propionic Acidemia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Propionic Acidemia Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Propionic Acidemia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Propionic Acidemia Market - TAM, US$ Billion, 2025
  • Figure 15: Global Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Propionic Acidemia Market, Sub-Segmentation Of L-Carnitine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Propionic Acidemia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Propionic Acidemia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Propionic Acidemia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Propionic Acidemia Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Propionic Acidemia Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Propionic Acidemia Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Propionic Acidemia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Propionic Acidemia Market - Company Scoring Matrix
  • Figure 96: Recordati Rare Diseases Inc Financial Performance
  • Figure 97: Horizon Therapeutics plc Financial Performance
  • Figure 98: Travere Therapeutics (Retrophin Inc) Financial Performance
  • Figure 99: Mitsubishi Tanabe Pharma Corporation Financial Performance
  • Figure 100: Ultragenyx Pharmaceutical Inc Financial Performance
  • Figure 101: Global Propionic Acidemia Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Propionic Acidemia Market, Competitive Dashboard
  • Figure 103: Global Propionic Acidemia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Propionic Acidemia Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 105: Global, Propionic Acidemia Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Figure 106: Global, Propionic Acidemia Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
No Related Insights

Malaria Vaccines Market Report 2026 - Global Outlook – By Agent (Plasmodium Falciparum, Plasmodium Vivax), By Vaccine Type (Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines), By Route Of Administration (Intr...

Hemp Based Foods Market Report 2026 - Global Outlook – By Product (Hemp Seed Oil, Hemp Protein Powder, Whole Hemp Seed, Hulled Hemp Seed), By Distribution Channel (Food Retail, Online and Specialty Or Health Stores), By ...

AIOps Market Report 2026 - Global Outlook – By Component (Platform, Services), By Organization Size (Small and Medium Enterprises, Large Enterprise), By Deployment Mode (On Premise, Cloud), By Application (Real-Time Anal...

Automotive Heads-Up Display Market Report 2026 - Global Outlook – By Head-Up Display Type ( Windshield Head-Up Display, Combiner Head-Up Display), By Technology ( Augmented Reality Head-Up Display, Conventional Head-Up D...

Ursolic Acid Market Report 2026 - Global Outlook – By Form (Powdered Form, Capsules, Liquid Form), By Type (25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, 98% Ursolic Acid, Other Types), By End-Use (Pharmaceutical...

Virtual Reality (VR) In Medical Simulation Market Report 2026 - Global Outlook – By Age Group (Adult, Children, Infant), By Application (Medical Education, Virtual Reality In Diagnostics, Pain Management, Mental Illness ...

Food Acidulants Market Report 2026 - Global Outlook – By Type (Citric Acid, Lactic Acid, Acetic Acid, Phosphoric Acid, Malic Acid, Other Types), By Form (Solid, Liquid), By Application (Beverages, Dairy And Frozen produc...

Frequently Asked Questions

The Propionic Acidemia market was valued at $2.07 billion in 2025, increased to $2.15 billion in 2026, and is projected to reach $2.53 billion by 2030.

The global Propionic Acidemia market is expected to grow at a CAGR of 4.1% from 2026 to 2035 to reach $2.53 billion by 2035.

Some Key Players in the Propionic Acidemia market Include, Major companies operating in the propionic acidemia market report are Recordati Rare Diseases Inc, Horizon Therapeutics plc, Travere Therapeutics (Retrophin Inc), Mitsubishi Tanabe Pharma Corporation, Ultragenyx Pharmaceutical Inc, Moderna Inc, Krystal Biotech Inc, Astellas Pharma Inc, Synlogic Inc, Encoded Therapeutics Inc, BridgeBio Pharma Inc, VectivBio AG, Agios Pharmaceuticals Inc, CoA Therapeutics Inc, Imbria Pharmaceuticals Inc, Comet Therapeutics Inc, Swedish Orphan Biovitrum AB (Sobi), Regenacy Pharmaceuticals, Audentes Therapeutics, Vertex Pharmaceuticals. .

Major trend in this market includes: Innovative mRNA-Based Therapies Advancing Treatment For Rare Genetic Disorders. For further insights on this market. request a sample here

North America was the largest region in the propionic acidemia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the propionic acidemia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us